Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Fresenius Medical Care
FMS
$12.2B
| $469K | ﹤0.01% |
20,729
+1,266
| +7% | +$28.4K |
|
|
CAI
2977
Caris Life Sciences
CAI
$7.89B
| $457K | ﹤0.01% |
25,652
-1,840
| -7% | -$32.9K |
|
2978
Microvast
MVST
$222M
| $457K | ﹤0.01% |
391,478
-1,971,528
| -83% | -$3.04M |
|
2979
Crown Crafts
CRWS
$26.9M
| $456K | ﹤0.01% |
160,727
-23,056
| -13% | -$63.8K |
|
2980
OptimumBank Holdings
OPHC
$116M
| $454K | ﹤0.01% |
77,662
+6,175
| +9% | +$34K |
|
|
STRR
2981
Star Equity Holdings
STRR
$36.2M
| $446K | ﹤0.01% |
41,861
| – | – |
|
2982
Sundial Growers
SNDL
$332M
| $443K | ﹤0.01% |
328,065
| – | – |
|
|
ARTV
2983
Artiva Biotherapeutics
ARTV
$443M
| $435K | ﹤0.01% |
44,815
+24,445
| +120% | +$223K |
|
2984
Grupo SIMEC
SIM
$4.65B
| $427K | ﹤0.01% |
14,169
| – | – |
|
|
PPLI
2985
People Inc
PPLI
$2.89B
| $424K | ﹤0.01% |
+9,179
| New | +$392K |
|
2986
HUTCHMED
HCM
$2.39B
| $419K | ﹤0.01% |
38,967
-17,002
| -30% | -$215K |
|
2987
MoonLake Immunotherapeutics
MLTX
$1.03B
| $411K | ﹤0.01% |
21,128
-5,179
| -20% | -$93.9K |
|
2988
Kentucky First Federal Bancorp
KFFB
$45.4M
| $410K | ﹤0.01% |
80,642
+22
| +0% | +$101 |
|
2989
Akebia Therapeutics
AKBA
$256M
| $408K | ﹤0.01% |
358,627
-563,296
| -61% | -$671K |
|
2990
GSI Technology
GSIT
$191M
| $393K | ﹤0.01% |
50,847
| – | – |
|
2991
Outset Medical
OM
$58.5M
| $392K | ﹤0.01% |
90,698
-22,667
| -20% | -$99.2K |
|
2992
Full House Resorts
FLL
$69.3M
| $391K | ﹤0.01% |
140,001
-40,185
| -22% | -$106K |
|
|
CLPR
2993
Clipper Realty
CLPR
$54M
| $390K | ﹤0.01% |
143,297
-1,725
| -1% | -$5.44K |
|
2994
Li Auto
LI
$11.5B
| $388K | ﹤0.01% |
33,022
-132,024
| -80% | -$2.16M |
|
2995
SmartRent
SMRT
$222M
| $387K | ﹤0.01% |
325,047
-209,061
| -39% | -$265K |
|
2996
Lightpath Technologies
LPTH
$663M
| $382K | ﹤0.01% |
23,343
-3,527
| -13% | -$49.2K |
|
2997
RxSight
RXST
$236M
| $373K | ﹤0.01% |
77,197
-90,146
| -54% | -$544K |
|
2998
AN2 Therapeutics
ANTX
$200M
| $368K | ﹤0.01% |
+76,045
| New | +$327K |
|
2999
Bluerock Homes Trust
BHM
$35.1M
| $359K | ﹤0.01% |
39,926
-866
| -2% | -$9.06K |
|
|
TECX
3000
Tectonic Therapeutic
TECX
$557M
| $359K | ﹤0.01% |
10,443
+366
| +4% | +$10.8K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.